Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Interferon-alpha (IFN-α) is a first-line drug for treating chronic hepatitis B (CHB). Guanylate-binding protein 1 (GBP1) is one of the interferon-stimulating factors, which participates in the innate immunity of the host and plays an antiviral and antibacterial role. In this study, we explored how G...

Full description

Bibliographic Details
Main Authors: Li Yadi, Luo Haiying, Hu Xiaoxia, Gong Jiaojiao, Tan Guili, Luo Huating, Wang Rui, Pang Hao, Yu Renjie, Qin Bo
Format: Article
Language:English
Published: Sciendo 2024-06-01
Series:Polish Journal of Microbiology
Subjects:
chronic hepatitis b
antiviral
hepatitis b virus
hepatitis b surface antigen
guanylate-binding protein 1 (gbp1)
pegylated interferon α-2b
Online Access:https://doi.org/10.33073/pjm-2024-021

Internet

https://doi.org/10.33073/pjm-2024-021

Similar Items